Provided by Tiger Fintech (Singapore) Pte. Ltd.

Azenta

30.52
+0.71002.38%
Post-market: 30.520.00000.00%16:20 EDT
Volume:321.95K
Turnover:9.79M
Market Cap:1.40B
PE:-12.64
High:30.72
Open:30.15
Low:29.65
Close:29.81
52wk High:55.64
52wk Low:23.91
Shares:45.84M
Float Shares:40.17M
Volume Ratio:0.76
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4141
EPS(LYR):-3.0874
ROE:-9.15%
ROA:-1.60%
PB:0.84
PE(LYR):-9.89

Loading ...

Insider Buying Highlights 3 Undervalued Small Caps Across Regions

Simply Wall St.
·
Sep 16

Repligen Corporation Appoints Violetta Hughes as Chief Accounting Officer to Enhance Financial Reporting Infrastructure

Reuters
·
Sep 02

Lawrence Y. Lin, EVP, CFO and Treasurer, Reports Acquisition of Azenta Inc. Common Shares

Reuters
·
Aug 13

Stock Track | Azenta Soars 6.52% Pre-Market Following Raymond James Upgrade to Outperform

Stock Track
·
Aug 06

Raymond James Upgrades Azenta to Outperform From Market Perform

MT Newswires Live
·
Aug 06

Azenta Down Over 16%, on Pace for Largest Percent Decrease Since May 2023 -- Data Talk

Dow Jones
·
Aug 06

Stock Track | Azenta Plummets 11% as Q3 Revenue Misses Estimates Despite EPS Growth

Stock Track
·
Aug 05

Azenta Q3 revenue flat, misses estimates; EPS rises

Reuters
·
Aug 05

Azenta Q3 Adj. EPS $0.19 Beats $0.13 Estimate, Sales $144.000M Miss $149.227M Estimate

Benzinga
·
Aug 05

Azenta Q3 Operating Income USD -700 Thousand

THOMSON REUTERS
·
Aug 05

Azenta Q3 Adjusted Ebitda Margin 12.3%

THOMSON REUTERS
·
Aug 05

Azenta - Reiterates FY 2025 Guidance

THOMSON REUTERS
·
Aug 05

Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance

THOMSON REUTERS
·
Aug 05

Azenta Inc: Collaboration With Frenova and Nephronomics for Genomic Research in Nephrology

THOMSON REUTERS
·
Aug 01

Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care

THOMSON REUTERS
·
Jul 31

Fresenius Medical Care AG Announces Strategic Collaboration to Advance Genomics-Driven Kidney Disease Care

Reuters
·
Jul 31

Azenta Inc. Announces Resignation of Chief Accounting Officer Violetta Hughes, Effective August 2025

Reuters
·
Jul 03

Azenta, Form Bio Launch Partnership for AAV Gene Therapy

MT Newswires Live
·
May 14

BRIEF-Azenta Life Sciences And Form Bio Announce Strategic Partnership To Advance AAV Gene Therapy Development

Reuters
·
May 14

Azenta Is Maintained at Buy by Needham

Dow Jones
·
May 08